Oleanoyl Pentapeptide Skin Hydration and Barrier Repair
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cosmetic treatments for skin aging, particularly expression lines, are inadequate as they either act slowly, are not potent enough, or cause undesirable side effects, failing to effectively inhibit facial muscle actions and rejuvenate the dermal layer effectively.
Innovation Solution
A composition containing a pentapeptide conjugate linked to oleanolic acid is used to enhance cellular communication, increasing gene and protein expression in skin cells, thereby promoting skin repair and firming by regulating Transforming Growth Factor-β and Fibroblast Growth Factor gene expressions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If single primary components (hydroxy acids or retinoic acid) are used to stimulate dermal cell re-growth, then cell proliferation is enhanced, but the treatment is not potent enough and causes undesirable side effects
Solution Approach 1:
The patent uses a composite composition containing multiple active ingredients (hydroxy acids, retinoic acid, and plant extracts) working synergistically to enhance dermal cell re-growth while reducing side effects. The combination allows each component to contribute to different aspects of skin regeneration, improving overall efficacy and tolerability compared to single-component treatments.
Solution Approach 2:
The patent introduces plant extracts as intermediary substances that mediate between the aggressive single-component treatments and the skin tissue. These plant-derived compounds act as buffers or modifiers that enhance the therapeutic effect while mitigating the harmful side effects of hydroxy acids and retinoic acid.
2Ease of operation
If muscle relaxant substances are used to inhibit facial expression muscles, then expression lines are reduced, but the effects are slow acting and not potent enough
Solution Approach 1:
The patent applies plant extracts topically to the skin in advance, allowing them to penetrate and prepare the dermal tissues before muscle contraction occurs. This preliminary action enables the active ingredients to be positioned in the skin, ready to rapidly counteract muscle deformation when expression lines form, thus achieving faster effects compared to systemic muscle relaxants.
Solution Approach 2:
The patent replaces the mechanical action of systemic muscle relaxant drugs with a topical plant extract application that directly作用于 the skin and dermal tissues. This substitution allows for localized, rapid action at the site of expression lines without the delayed systemic absorption and distribution associated with oral or injectable muscle relaxants.
Data Source
AI summary
Disclosed is the a method of effecting skin hydration and enhancing skin barrier function, said method comprising the step of bringing into contact a pentapeptide conjugate of oleanolic acid with skin cells so that the effect of increased cellular communication at the molecular level to bring about gene and protein expression in the cells of the skin that enable hydration and skin barrier functions are realized.